XL Sci Tech Inc

Medtech · Private

PET-enabled Y-90 radioembolic glass microspheres for liver cancer treatment with real-time imaging guidance

Grants
$6.1M
6 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · Radioactive Stents for Brachytherapy of Esophageal Cancers$802,308
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · Radioactive Stents for Brachytherapy of Esophageal Cancers$1,551,134
Federal grantDepartment of Health and Human Services · Phase II · PET Enabled Microspheres for Radioembolization of Liver Tumors$744,464
Federal grantDepartment of Health and Human Services · Phase II · Radioactive Stents for Brachytherapy of Esophageal Cancers$748,826
Federal grantDepartment of Health and Human Services · Phase II · PET Enabled Y-90 Microspheres for Radioembolization of Liver Tumors$1,120,462
Federal grantDepartment of Health and Human Services · Phase II · PET Enabled Y-90 Microspheres for Radioembolization of Liver Tumors$1,165,716
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2089REDWOOD NEURO INC.——
2090CLEAR GENE INC——
2091PRIVO TECHNOLOGIES, LLC——
2092XL Sci Tech Inc——
2093VDF INDUSTRIES INC——
2094Cognext Diagnostics LLC——
2095AURICLE HEALTH INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Particulate Materials And Compositions For Radio Therapyapplication
  • Particulate Materials And Compositions For Radio Therapyapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.